Lifecore Biomedical, Inc. \De\

Ownership Transactions Reported by 24 Insiders

Symbol
LFCR on Nasdaq
Industry
Pharmaceutical Preparations
Location
3515 Lyman Boulevard, Chaska, MN

There are no Buy or Sell transactions made by insiders since 9/17/2023

Lifecore Biomedical, Inc. \De\ executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Wynnefield Partners Small Cap Value Lp I 10%+ Owner $35.2M Jan 9, 2023
Christopher S. Kiper Director $31.2M Jul 8, 2024
Paul Josephs Chief Executive Officer, Director $5.38M May 20, 2024
James Hall Chief Executive Officer, Director $2.88M Jun 1, 2023
Ryan Lake Chief Financial Officer $2.74M Sep 3, 2024
John Morberg Chief Financial Officer $1.31M Jan 18, 2024
Nelson Obus Director $1.24M Jul 8, 2024
Lovas Katrina Houde Director $937K Jul 8, 2024
Joshua Schechter Director $934K Jul 8, 2024
Craig A. Barbarosh Director $918K Jul 8, 2024
Jeffrey L. Edwards Director $830K Jul 8, 2024
Albert D. Bolles Chief Executive Officer $759K May 23, 2022
Raymond Diradoorian Director $729K Jul 8, 2024
Tonia L. Pankopf Director $621K Jun 4, 2022
Nathaniel Calloway Director $605K Jul 8, 2024
Catherine A. Sohn Director $563K Jun 4, 2022
Deborah Carosella Director $381K Jun 4, 2022
Humberto C. Antunes Director $287K Aug 19, 2024
Andrew Kenneth William Powell Director $286K Jun 4, 2022
Jason Aryeh Director $256K Aug 19, 2024
Paul Harold Johnson Director $256K Aug 19, 2024
Matthew E. Korenberg Director $256K Aug 19, 2024
Timothy P. Burgess Senior VP of Supply Chain $240K Jul 27, 2021
Patrick D. Walsh Director $49.4K Jun 4, 2021

Recent Insider Transactions by Companies or Individuals for Lifecore Biomedical, Inc. \De\

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.